Seminars in Oncology
Volume 30, Issue 5 , Pages 587-595, October 2003

Conservative versus radical therapy of prostate cancer: how have recent advances in molecular markers and imaging enhanced our ability to prognosticate risk?

  • Scott Bagnall

      Affiliations

    • Sunnybrook & Women’s College Health Sciences Centre, Toronto, Canada
    • ,
  • Laurence Klotz

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Laurence Klotz, MD, Sunnybrook & Women’s College Health Sciences Centre, 2075 Bayview Ave #MG 408, Toronto, Ontario M4N 3M5, Canada
    • Sunnybrook & Women’s College Health Sciences Centre, Toronto, Canada

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0093-7754(03)00348-8

doi:10.1016/S0093-7754(03)00348-8

Seminars in Oncology
Volume 30, Issue 5 , Pages 587-595, October 2003

Article Tools

* Image Usage & Resolution